HOOKIPA PHARMA INC's ticker is HOOK and the CUSIP is 43906K100. A total of 55 filers reported holding HOOKIPA PHARMA INC in Q3 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9 | -25.0% | 14 | 0.0% | 0.00% | – |
| Q2 2023 | $12 | – | 14 | 0.0% | 0.00% | – |
| Q1 2023 | $0 | – | 14 | 0.0% | 0.00% | – |
| Q4 2022 | $0 | – | 14 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 14 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 14 | -99.8% | 0.00% | – |
| Q1 2022 | $21,000 | -90.2% | 9,016 | -90.2% | 0.00% | – |
| Q4 2021 | $215,000 | -49.9% | 92,293 | +26.6% | 0.00% | – |
| Q3 2021 | $429,000 | +530.9% | 72,893 | +884.2% | 0.00% | – |
| Q2 2021 | $68,000 | -86.5% | 7,406 | -80.2% | 0.00% | – |
| Q1 2021 | $504,000 | +34.0% | 37,447 | +10.4% | 0.00% | – |
| Q4 2020 | $376,000 | +308.7% | 33,931 | +259.1% | 0.00% | – |
| Q3 2020 | $92,000 | -22.0% | 9,450 | -7.1% | 0.00% | – |
| Q2 2020 | $118,000 | -11.9% | 10,174 | -37.5% | 0.00% | – |
| Q1 2020 | $134,000 | -16.8% | 16,288 | +24.0% | 0.00% | – |
| Q4 2019 | $161,000 | +3120.0% | 13,136 | +1817.7% | 0.00% | – |
| Q3 2019 | $5,000 | +25.0% | 685 | +19.3% | 0.00% | – |
| Q2 2019 | $4,000 | – | 574 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 1,842,902 | $17,452,000 | 0.32% |
| Samsara BioCapital, LLC | 116,602 | $1,104,000 | 0.31% |
| Artal Group S.A. | 599,616 | $5,678,000 | 0.14% |
| HHLR ADVISORS, LTD. | 943,254 | $8,933,000 | 0.07% |
| DAFNA Capital Management LLC | 22,061 | $209,000 | 0.07% |
| Baker Brothers Advisors | 700,481 | $6,634,000 | 0.03% |
| ZACKS INVESTMENT MANAGEMENT | 72,064 | $682,000 | 0.01% |
| HOWLAND CAPITAL MANAGEMENT LLC | 14,728 | $139,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 14,374 | $139,000 | 0.00% |
| Squarepoint Ops LLC | 12,699 | $120,000 | 0.00% |